Abstract | OBJECTIVE: METHODS: NMO lesions were produced in mice by intracerebral injection of immunoglobulin G ( IgG) isolated from NMO patient serum and human complement. We previously reported that this mouse model produces the characteristic histological features of NMO, including perivascular complement activation, inflammatory cell infiltration, and loss of myelin, AQP4, and glial fibrillary acidic protein. Lesions are absent when AQP4 null mice are used or when IgG from non-NMO patients is injected. RESULTS: INTERPRETATION: Our data implicate a central role of neutrophils in the pathogenesis of early NMO lesions and suggest the potential utility of neutrophil protease inhibitors such as Sivelestat in NMO therapy.
|
Authors | Samira Saadoun, Patrick Waters, Claire MacDonald, B Anthony Bell, Angela Vincent, A S Verkman, Marios C Papadopoulos |
Journal | Annals of neurology
(Ann Neurol)
Vol. 71
Issue 3
Pg. 323-33
(Mar 2012)
ISSN: 1531-8249 [Electronic] United States |
PMID | 22374891
(Publication Type: Comparative Study, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2012 American Neurological Association. |
Chemical References |
- Immunoglobulin G
- Protease Inhibitors
|
Topics |
- Animals
- Brain
(drug effects, enzymology, pathology)
- Humans
- Immunoglobulin G
(toxicity)
- Mice
- Mice, Knockout
- Neuromyelitis Optica
(drug therapy, enzymology, pathology)
- Neutrophils
(drug effects, enzymology, pathology)
- Protease Inhibitors
(pharmacology, therapeutic use)
|